Table 1.
Variable |
Overall |
Excluding patients with severe constipation |
P value |
|||
A (mosapride) | B (placebo) | C (mosapride) | D (placebo) | A vs B | C vs D | |
No. of patients | 124 | 125 | 108 | 120 | ||
Age (yr, mean ± SD) | 67.3 ± 8.6 | 67.8 ± 10.1 | 67.3 ± 8.5 | 67.5 ± 10.2 | NS | NS |
< 60 | 21 | 21 | 18 | 21 | NS | NS |
60-69 | 42 | 44 | 37 | 42 | ||
≥ 70 | 61 | 60 | 53 | 57 | ||
Male | 69 | 83 | 64 | 80 | NS | NS |
Female | 55 | 42 | 44 | 40 | ||
Body mass index (kg/m2, mean ± SD) | 22.5 ± 2.9 | 22.6 ± 2.7 | 22.7 ± 2.9 | 22.7 ± 2.6 | NS | NS |
Bowel movements per week | ||||||
< 2 | 16 | 5 | 0 | 0 | < 0.05 | NS |
≥ 2 | 108 | 120 | 108 | 120 | ||
Previous colonoscopy | ||||||
None (first time) | 38 | 27 | 32 | 26 | NS | NS |
≥ 2 | 86 | 98 | 76 | 94 |
P value by the χ2 test. NS: Not significant.